Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos One|May 17, 2011
IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathwayXin Duan, Larissa Ponomareva, Sudhakar Veeranki, et al.
Canadian Journal of Physiology and Pharmacology|July 12, 2016
Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertensionSudhakar Veeranki, Siva K Gandhapudi, Suresh C Tyagi
Biochimica Et Biophysica Acta|January 24, 2015
Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modificationsSudhakar Veeranki, Lee J Winchester, Suresh C Tyagi
American Journal of Physiology. Heart and Circulatory Physiology|March 4, 2014
Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemiaSudhakar Veeranki, Srikanth Givvimani, Sathnur Pushpakumar, et al.
Differentiation; Research in Biological Diversity|August 5, 2008
The function of PP2A/B56 in non-metazoan multicellular developmentNam-Sihk Lee, Sudhakar Veeranki, Bohye Kim, et al.
Annals of the New York Academy of Sciences|February 6, 2016
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exerciseIlya Chernyavskiy, Sudhakar Veeranki, Utpal Sen, et al.
Canadian Journal of Physiology and Pharmacology|June 14, 2014
Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytesLee Winchester, Sudhakar Veeranki, Srikanth Givvimani, et al.
Canadian Journal of Physiology and Pharmacology|June 7, 2014
Dysregulation of Mfn2 and Drp-1 proteins in heart failureSrikanth Givvimani, Sathnur Pushpakumar, Sudhakar Veeranki, et al.
Physiological Reports|March 30, 2018
Exercise mitigates the effects of hyperhomocysteinemia on adverse muscle remodelingLee J Winchester, Sudhakar Veeranki, Sathnur Pushpakumar, et al.
Plos One|November 3, 2011
IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomesSudhakar Veeranki, Xin Duan, Ravichandran Panchanathan, et al.
Pageof 4